Pricing Log in Create free account

Curis, Inc. (CRIS) vs Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI)

Curis, Inc. and Scinai Immunotherapeutics Ltd. Sponsored ADR are both Biotechnology companies. Curis, Inc. is the larger, with a market value of $1.1M against $640.0K — 1.7× the size. Curis, Inc. has negative trailing earnings, so its P/E is not meaningful; Scinai Immunotherapeutics Ltd. Sponsored ADR trades at 0.0×. Across the 11 metrics below, Scinai Immunotherapeutics Ltd. Sponsored ADR leads on 7 and Curis, Inc. on 4.

Valuation

Metric CRIS SCNI Biotechnology median
P/E n/m 0.01 8.50
P/S 0.09 n/m 9.71
P/B 0.19 0.05 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.41 0.28 0.64
EV/Sales (0.37) n/m 9.21
Earnings yield (3,468.29%) 11,368.55% (33.15%)
Free cash flow yield (3,540.29%) (2,331.48%) (25.50%)

Profitability

Metric CRIS SCNI Biotechnology median
Gross margin 99.52% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 455.35% 0.00% (56.36%)
Return on assets (87.76%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRIS SCNI Biotechnology median
Revenue growth (TTM) (13.43%) — 6.02%
EPS growth (last fiscal year) 91.57% (159.83%) 30.26%
Revenue growth, 5-year CAGR (2.71%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRIS SCNI Biotechnology median
Debt to equity 0.00 0.02 0.00
Current ratio 0.49 1.56 4.72
Net debt to EBITDA 0.91 0.25 0.96

Dividend

Metric CRIS SCNI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRIS SCNI Biotechnology median
Market cap 1.06m 640.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack